Abbott Laboratories (ABT) Ratios
Abbott Laboratories Ratios
MX:ABT's free cash flow for Q2 2026 was $2.89B. For the 2026 fiscal year, MX:ABT's free cash flow was increased by $399.00M and operating cash flow was $2.49B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 |
| Quick Ratio | 1.18 | 1.23 | 1.16 | 1.23 | 1.46 |
| Cash Ratio | 0.52 | 0.54 | 0.50 | 0.64 | 0.75 |
| Solvency Ratio | 0.28 | 0.50 | 0.26 | 0.27 | 0.27 |
| Operating Cash Flow Ratio | 0.58 | 0.60 | 0.52 | 0.62 | 0.80 |
| Short-Term Operating Cash Flow Coverage | 2.89 | 4.88 | 5.48 | 3.86 | 10.54 |
| Net Current Asset Value | $ -7.95B | $ -9.86B | $ -11.72B | $ -12.31B | $ -14.93B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.19 | 0.22 | 0.24 | 0.26 |
| Debt-to-Equity Ratio | 0.29 | 0.32 | 0.41 | 0.49 | 0.54 |
| Debt-to-Capital Ratio | 0.22 | 0.24 | 0.29 | 0.33 | 0.35 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.21 | 0.26 | 0.28 | 0.33 |
| Financial Leverage Ratio | 1.66 | 1.71 | 1.90 | 2.03 | 2.10 |
| Debt Service Coverage Ratio | 2.73 | 7.31 | 4.78 | 3.76 | 7.82 |
| Interest Coverage Ratio | 23.60 | 11.32 | 9.22 | 26.55 | 22.44 |
| Debt to Market Cap | 0.06 | 0.07 | 0.08 | 0.09 | 0.07 |
| Interest Debt Per Share | 8.82 | 9.17 | 9.56 | 10.42 | 11.08 |
| Net Debt to EBITDA | 0.55 | 0.71 | 0.85 | 0.68 | 0.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.51% | 50.83% | 49.96% | 51.14% | 53.89% |
| EBIT Margin | 19.87% | 18.15% | 18.35% | 19.75% | 20.01% |
| EBITDA Margin | 26.90% | 25.83% | 26.44% | 27.23% | 28.23% |
| Operating Profit Margin | 18.16% | 16.27% | 16.04% | 19.16% | 21.36% |
| Pretax Profit Margin | 19.10% | 16.72% | 16.61% | 19.03% | 19.06% |
| Net Profit Margin | 14.72% | 31.95% | 14.27% | 15.88% | 16.42% |
| Continuous Operations Profit Margin | 14.72% | 31.95% | 14.27% | 15.88% | 16.42% |
| Net Income Per EBT | 77.06% | 191.10% | 85.88% | 83.47% | 86.12% |
| EBT Per EBIT | 105.19% | 102.75% | 103.56% | 99.33% | 89.25% |
| Return on Assets (ROA) | 7.52% | 16.46% | 7.82% | 9.31% | 9.40% |
| Return on Equity (ROE) | 12.51% | 28.12% | 14.83% | 18.90% | 19.75% |
| Return on Capital Employed (ROCE) | 11.46% | 10.15% | 10.84% | 14.19% | 14.82% |
| Return on Invested Capital (ROIC) | 8.43% | 9.89% | 9.10% | 11.36% | 12.56% |
| Return on Tangible Assets | 11.42% | 25.94% | 14.05% | 16.83% | 18.03% |
| Earnings Yield | 2.98% | 6.84% | 3.00% | 3.60% | 2.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.59 | 6.06 | 6.11 | 7.02 | 6.64 |
| Payables Turnover | 4.65 | 4.92 | 4.67 | 4.63 | 4.51 |
| Inventory Turnover | 3.04 | 3.33 | 3.06 | 3.46 | 3.85 |
| Fixed Asset Turnover | 3.43 | 3.58 | 3.56 | 4.25 | 4.26 |
| Asset Turnover | 0.51 | 0.52 | 0.55 | 0.59 | 0.57 |
| Working Capital Turnover Ratio | 4.67 | 4.58 | 4.32 | 4.18 | 4.38 |
| Cash Conversion Cycle | 106.89 | 95.63 | 101.11 | 78.79 | 68.73 |
| Days of Sales Outstanding | 65.29 | 60.25 | 59.74 | 51.99 | 54.97 |
| Days of Inventory Outstanding | 120.08 | 109.62 | 119.47 | 105.63 | 94.77 |
| Days of Payables Outstanding | 78.47 | 74.24 | 78.10 | 78.84 | 81.01 |
| Operating Cycle | 185.37 | 169.87 | 179.22 | 157.62 | 149.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.48 | 4.94 | 4.19 | 5.47 | 5.93 |
| Free Cash Flow Per Share | 4.23 | 3.67 | 2.92 | 4.45 | 4.87 |
| Dividend Paid and CapEx Coverage Ratio | 1.52 | 1.42 | 1.26 | 1.88 | 2.07 |
| Capital Expenditure Coverage Ratio | 4.41 | 3.88 | 3.30 | 5.39 | 5.59 |
| Operating Cash Flow Coverage Ratio | 0.63 | 0.56 | 0.46 | 0.53 | 0.55 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.20 | 0.18 | 0.22 | 0.24 |
| Free Cash Flow Yield | 3.38% | 3.24% | 2.65% | 4.05% | 3.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.50 | 14.75 | 33.35 | 27.76 | 35.33 |
| Price-to-Sales (P/S) Ratio | 4.94 | 4.67 | 4.76 | 4.41 | 5.80 |
| Price-to-Book (P/B) Ratio | 4.20 | 4.11 | 4.94 | 5.25 | 6.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 29.60 | 30.84 | 37.73 | 24.66 | 28.89 |
| Price-to-Operating Cash Flow Ratio | 22.88 | 22.89 | 26.29 | 20.09 | 23.72 |
| Price-to-Earnings Growth (PEG) Ratio | -0.65 | 0.11 | -2.05 | -36.74 | 0.61 |
| Enterprise Value Multiple | 18.91 | 18.79 | 18.84 | 16.87 | 21.32 |
| Enterprise Value | 225.43B | 203.53B | 199.85B | 200.53B | 259.27B |
| EV to EBITDA | 18.91 | 18.79 | 18.84 | 16.87 | 21.32 |
| EV to Sales | 5.09 | 4.85 | 4.98 | 4.59 | 6.02 |
| EV to Free Cash Flow | 30.48 | 32.05 | 39.50 | 25.70 | 29.98 |
| EV to Operating Cash Flow | 23.57 | 23.78 | 27.52 | 20.93 | 24.61 |
| Tangible Book Value Per Share | 13.29 | 10.48 | 3.65 | 2.08 | 0.03 |
| Shareholders’ Equity Per Share | 29.84 | 27.52 | 22.26 | 20.93 | 20.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | -0.91 | 0.14 | 0.17 | 0.14 |
| Revenue Per Share | 25.37 | 24.22 | 23.13 | 24.90 | 24.27 |
| Net Income Per Share | 3.73 | 7.74 | 3.30 | 3.95 | 3.98 |
| Tax Burden | 0.77 | 1.91 | 0.86 | 0.83 | 0.86 |
| Interest Burden | 0.96 | 0.92 | 0.91 | 0.96 | 0.95 |
| Research & Development to Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 |
| SG&A to Revenue | 0.28 | 0.28 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
| Income Quality | 1.47 | 0.64 | 1.27 | 1.38 | 1.49 |
Currency in USD